Compare · CBUS vs NXTS
CBUS vs NXTS
Side-by-side comparison of Cibus Inc. (CBUS) and Nexentis Technologies Inc. (NXTS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBUS and NXTS operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- CBUS is the larger of the two at $86.6M, about 58.8x NXTS ($1.5M).
- NXTS has been more active in the news (17 items in the past 4 weeks vs 7 for CBUS).
- CBUS has more recent analyst coverage (4 ratings vs 0 for NXTS).
- Company
- Cibus Inc.
- Nexentis Technologies Inc.
- Price
- -
- -
- Market cap
- $86.6M
- $1.5M
- 1M return
- -12.11%
- -
- 1Y return
- -9.27%
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- News (4w)
- 7
- 17
- Recent ratings
- 4
- 0
Latest CBUS
- Sr VP, Research Sauer Noel covered exercise/tax liability with 1,839 shares, decreasing direct ownership by 1% to 138,040 units (SEC Form 4)
- CAO, Gen Csl & Corp Secy Stokes Jason covered exercise/tax liability with 3,519 shares, decreasing direct ownership by 2% to 164,346 units (SEC Form 4)
- CFO Broos Carlo covered exercise/tax liability with 2,537 shares, decreasing direct ownership by 2% to 151,738 units (SEC Form 4)
- SEC Form 10-Q filed by Cibus Inc.
- Cibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cibus Reports Third Quarter Financial Results and Provides Business Update
- Cibus to Report Third Quarter 2026 Financial Results on November 12, 2026 After the Market Close and Host Conference Call
- Cibus and Crystal Crop Protection Team Up to Improve India’s Mustard Crop
- SEC Form 10-Q filed by Cibus Inc.
- Cibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest NXTS
- Nexentis Technologies Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- SEC Form PRE 14A filed by Nexentis Technologies Inc.
- Nexentis Technologies Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Nexentis Announces Reverse Stock Split
- Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz
- Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
- SEC Form 4 filed by Nexentis Technologies Inc.
- SEC Form PRE 14A filed by Nexentis Technologies Inc.
- SEC Form 8-K filed by Nexentis Technologies Inc.
- SEC Form 4 filed by Nexentis Technologies Inc.